fast tack

FDA grants ARX788 fast track designation for HER2-positive metastatic breast cancer
Pharmaceutical Business Review
Tue, 01/5/21 - 09:57 am
Ambrx
FDA
ARX788
HER-2 postive breast cancer
fast tack